Home › Stocks › SXTPW

SXTPW — 60 DEGREES PHARMACEUTICALS I

Reported value held$645
Funds holding (latest)3
SectorHealth Care
Funds holding (Q2 2026)1
Institutional value$20 · 647 sh
New / Add / Cut / Exit0 / 0 / 1 / 1
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Reducing -95.1% (-12.46K sh)
Institutional value change Down -97.0%

As of Q2 2026, 1 SEC-registered investment managers reported holding SXTPW (60 DEGREES PHARMACEUTICALS I) in their latest 13F filings, with a combined reported value of $20 across 647 shares. That is -95.1% by share count (-12.46K shares) versus the previous quarter, while reported value moved -97.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 1 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

SXTPW is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

FundQuarterSharesValuePortfolio WeightChange
Citadel Advisors history Q1 2026 12.40K $621 0.00% Reduce
UBS Group AG history Q2 2026 647 $20 0.00% Reduce
Bank of America Corp history Q4 2023 100 $4 0.00% Hold

New Positions (Q2 2026)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 3 funds)

FundQ3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
UBS Group AG 6.07K 100 248 — 80 506 — 1.50K 814 788 702 647
Citadel Advisors — — 27.52K 39.04K 46.27K 47.67K 42.42K 17.67K 20.80K 15.57K 12.40K —
Bank of America Corp 100 100 — — — — — — — — — —

Download holders (CSV)